2014
An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation
Chaloupka FJ, Warner KE, Acemoğlu D, Gruber J, Laux F, Max W, Newhouse J, Schelling T, Sindelar J. An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation. Tobacco Control 2014, 24: 112. PMID: 25550419, PMCID: PMC4345832, DOI: 10.1136/tobaccocontrol-2014-052022.Peer-Reviewed Original ResearchConceptsEconomic impact analysisSound economic analysisNet economic benefitsImpact analysisProminent economistsSignificant regulatory actionsEconomic analysisDrug Administration's regulatory authorityNet benefitEconomic benefitsTobacco productsGraphic warning labelsRegulatory authoritiesLabel regulationsCostTobacco product regulationRegulatory actionProduct regulationEconomistsAuthoritiesBenefitsFuture analysesRulesControl ActJurisdictions
2004
Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes
Sindelar JL, Jofre-Bonet M, French MT, McLellan AT. Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes. Drug And Alcohol Dependence 2004, 73: 41-50. PMID: 14687958, DOI: 10.1016/j.drugalcdep.2003.09.002.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlcoholismAmbulatory CareCase ManagementData CollectionData Interpretation, StatisticalFemaleFinancing, GovernmentFollow-Up StudiesHumansIllicit DrugsMaleOutcome and Process Assessment, Health CarePhiladelphiaPrepaid Health PlansRehabilitationRehabilitation, VocationalReproducibility of ResultsSocial AdjustmentSocial WorkSubstance-Related DisordersUrban Health ServicesConceptsCost-effectiveness analysisDrug Abuse Treatment Cost Analysis ProgramCost-benefit analysisCost-effectiveness ratioEmpirical examplePolicy inferencesEconomic analysisEconomic evaluationConflicting implicationsCost dataPaper identifiesMethodological principlesVariety of outcomesMultiple outcomesRange of outcomesSingle outcomeDifferent outcomesEmploymentAppropriate approachImplicationsParadox